The United States Patent and Trademark Office (USPTO) has introduced a pilot program to provide prioritized patent examination for patent applications that cover a product or process related to COVID-19. The product or process must be subject to an applicable U.S. Food and Drug Administration (FDA) approval for COVID-19 use.Continue reading
Author Archive: AZBio
UArizona, State of Arizona to Expand COVID-19 Antibody Testing Statewide
Tucson, Ariz. – The University of Arizona and state of Arizona antibody testing initiative will include 31 sites across the state as it expands to all 15 counties.Continue reading
Cloth masks are a worthy line of defense to mitigate COVID-19 pandemic
Sarah Arrowsmith, lab coordinator and scientist at Biodesign Institute Center for Environmental Biotechnology, stepped up to make coth masks for others. The team at the ASU Biodesign institute ran tests to determine how effective these homemade masks may be. Continue reading
Dr. Michelle McMurry-Heath will become BIO’s President and CEO on June 1, 2020
After a comprehensive search, the Biotechnology Innovation Organization (BIO) has announced that Michelle McMurry-Heath, MD, PhD, as its incoming President and CEO. McMurry-Heath will become the organization’s next President and CEO on June 1, 2020.
BIO is the world’s largest science and public advocacy organization, representing 1,000 members. McMurry-Heath will succeed former Rep. Jim Greenwood, who has led the organization since 2005 and BIO’s founding President & CEO Carl B. Feldbaum who served from 1993 to 2004.Continue reading
ICYMI: Testing, Testing, Testing
- Testing – What is the difference between tests?
- Testing – Who needs it and when?
- Testing – How can we get the job done?
Continue reading
New Executive Order: Stay Healthy, Return Smarter, Return Stronger
“This is not a green light to speed, this is a green light to proceed, and we are going to proceed with caution,” Arizona Governor Doug DuceyContinue reading
Biotechnology Innovation Organization Launches New Medicine Pipeline Tracker Illustrates Unprecedented Effort to Eradicate COVID-19
Washington, DC (May 12, 2020) – The Biotechnology Innovation Organization (BIO) today unveiled a first-of-its-kind, interactive tracker of the new treatments and vaccines in the COVID-19 pipeline. This online resource illustrates the unprecedented campaign being undertaken by biopharmaceutical innovators to combat – and ultimately eradicate – the novel coronavirus. Continue reading
Express Scripts Offers Prescription Cost Relief for Newly Uninsured Americans
- Unprecedented program convenes manufacturers and pharmacies to help millions of Americans access prescription medications at affordable and predictable prices
- Express Scripts Parachute RxSM will cap costs at $25 for a 30-day supply of generic drugs; $75 for a 30-day supply of brand-name medicines for a limited time
AdvaMed Issues MedTech Compliance Guidance For COVID-19 Response
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”
“This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate any related compliance risks,” said Christopher L. White, AdvaMed COVID action team leader, chief operating officer and general counsel.Continue reading
What is the Bipartisan Commission on Biodefense?
On January 20, 2019, AZBio hosted a thought leadership event at Barrett-Jackson Scottsdale featuring a panel discussion on Health Innovation with Dr. Anna Barker and Dr. George Poste. During the discussion, Dr. Poste, shared his thoughts on the need for governments and our industry to prepare for global pandemics and what the Bipartisan Commission on Biodefense had reported. Dr. Poste, an ex officio member of the commission, shared that is was not a matter of if a global pandemic would occur, but of when.
The first report of a COVID-19 case in the U.S. was January 20, 2020. Today, the world is learning more about what happens in a global pandemic than we ever wanted to know. And, we still have a lot more to learn.Continue reading